Search research articles
Contact Us
Filters
Showing results (41-50 of 83) with videos related to
Page
of 9
Sort By:
Oncotarget
|
January 2, 2018
Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients
Karen Klepsland Mauland, Zhenlin Ju, Ingvild Løberg Tangen, et al.
Cancer Cell
|
October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors
Lydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
Nature Methods
|
September 17, 2013
TCPA: a resource for cancer functional proteomics data
Jun Li, Yiling Lu, Rehan Akbani, et al.
Plos One
|
October 7, 2020
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA
Noriyuki Sasaki, Takeshi Iwaya, Takehiro Chiba, et al.
Cancer Discovery
|
June 13, 2015
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Jianfeng Shen, Yang Peng, Leizhen Wei, et al.
The Journal of Clinical Investigation
|
October 5, 2020
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors
Lulu Wang, Lin Yang, Chen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
Michael A Davies, Katherine Stemke-Hale, E Lin, et al.
Oncotarget
|
June 14, 2019
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options
Marilyne Labrie, Tae-Beom Kim, Zhenlin Ju, et al.
British Journal of Cancer
|
March 4, 2021
Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling
Mizunori Yaegashi, Takeshi Iwaya, Noriyuki Sasaki, et al.
Molecular & Cellular Proteomics : MCP
|
March 14, 2018
Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies
Jinho Lee, Gary K Geiss, Gokhan Demirkan, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 83) with videos related to
Sort By:
Page
of 9
Oncotarget
|
January 2, 2018
Proteomic profiling of endometrioid endometrial cancer reveals differential expression of hormone receptors and MAPK signaling proteins in obese versus non-obese patients
Karen Klepsland Mauland, Zhenlin Ju, Ingvild Løberg Tangen, et al.
Cancer Cell
|
October 7, 2014
Naturally occurring neomorphic PIK3R1 mutations activate the MAPK pathway, dictating therapeutic response to MAPK pathway inhibitors
Lydia W T Cheung, Shuangxing Yu, Dong Zhang, et al.
Nature Methods
|
September 17, 2013
TCPA: a resource for cancer functional proteomics data
Jun Li, Yiling Lu, Rehan Akbani, et al.
Plos One
|
October 7, 2020
Analysis of mutational and proteomic heterogeneity of gastric cancer suggests an effective pipeline to monitor post-treatment tumor burden using circulating tumor DNA
Noriyuki Sasaki, Takeshi Iwaya, Takehiro Chiba, et al.
Cancer Discovery
|
June 13, 2015
ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors
Jianfeng Shen, Yang Peng, Leizhen Wei, et al.
The Journal of Clinical Investigation
|
October 5, 2020
Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors
Lulu Wang, Lin Yang, Chen Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 10, 2009
Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma
Michael A Davies, Katherine Stemke-Hale, E Lin, et al.
Oncotarget
|
June 14, 2019
Adaptive responses in a PARP inhibitor window of opportunity trial illustrate limited functional interlesional heterogeneity and potential combination therapy options
Marilyne Labrie, Tae-Beom Kim, Zhenlin Ju, et al.
British Journal of Cancer
|
March 4, 2021
Frequent post-operative monitoring of colorectal cancer using individualised ctDNA validated by multiregional molecular profiling
Mizunori Yaegashi, Takeshi Iwaya, Noriyuki Sasaki, et al.
Molecular & Cellular Proteomics : MCP
|
March 14, 2018
Implementation of a Multiplex and Quantitative Proteomics Platform for Assessing Protein Lysates Using DNA-Barcoded Antibodies
Jinho Lee, Gary K Geiss, Gokhan Demirkan, et al.
Page
of 9